11beta-methyl-19-nortestosterone 17beta-dodecylcarbonate (University of Washington/Los Angeles Biomedical Research Institute/Eunice Kennedy Shriver National Institute of Child Health and Human Development)

N/A

报告时间: 2025/06/09 17:38:17

NME

基本信息

药物名称11beta-methyl-19-nortestosterone 17beta-dodecylcarbonate (University of Washington/Los Angeles Biomedical Research Institute/Eunice Kennedy Shriver National Institute of Child Health and Human Development)

药物别称11beta-MNTDC

药物类型化学药 > 甾体类

作用机制NAD(+) hydrolase SARM1 modulators

靶点NAD(+) hydrolase SARM1

治疗领域 / 适应症避孕

全球批准适应症N/A

中国批准适应症N/A

首批国家/区域N/A

首批日期N/A

国家/区域美国

是否复方否

全球最高研发状态临床一期

中国最高研发状态N/A

原研公司University Of Washington

注册分类N/A

研发信息

活跃公司Eunice Kennedy Shriver Institute Of Child Health And Human Development Lundquist Institute University Of Washington

非活跃公司N/A

活跃适应症避孕

非活跃适应症N/A

其他信息

ATC代码N/A